The ambulatory surgery center (ASC) industry experienced another transformative year in 2024, marked by accelerated growth, evolving case complexity, and continued regulatory shifts. Strategic ...
Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...